The national health insurance to start expanding the scope of the national centralized purchasing of drugs, so that many **** win, but why individual manufacturers won the tender

Basic medical insurance drugs are drugs that are necessary to ensure the clinical treatment of employees and are included in the scope of basic medical insurance payments, which are divided into two categories: Category A and Category B. The first category of drugs are those that are necessary to ensure the clinical treatment of employees and are included in the scope of basic medical insurance payments.

Category A drugs are those that are basically uniform across the country and can guarantee the basic needs of clinical treatment.

1, the cost of such drugs are included in the scope of payment of the basic medical insurance fund, and the cost is paid according to the standard of payment of the basic medical insurance.

2. Drugs in category B are those for which the basic medical insurance fund is partially capable of paying the costs, and these drugs are first paid for by the employees at a certain percentage before being included in the scope of the basic medical insurance fund's benefits and the costs are paid according to the standard of the basic medical insurance benefits.

3, the winning drug refers to the government to implement a unified procurement, meaning that the state of the prescription drugs by the government unified tender, the tender includes, drug brands, prices, specifications, dosage forms, etc., each bidding business in the bidding for drugs before the start of the bidding for the bidding information submitted to the government bidding office, the bidding office by the unified evaluation, and then decided to win the bid. The products can be sold in hospitals only after winning the bidding.